Endothelin concentrations in preterm infants treated with human recombinant erythropoietin

Biology of the Neonate

Volumn 77, Issue 2, 2000, Pages 105-108

  Cogar, Allison A ^a   Hartenberger, Carol H ^a   Ohls, Robin K ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelin 1; Erythropoietin; Hypertension

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; HYPERTENSION; NEWBORN; PREMATURITY; PRIORITY JOURNAL;

EID: 0033965672     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014203     Document Type: Article

References (19)

1. Ohls RK: Erythropoietin to prevent and treat the anemia of prematurity. Curr Opin Pediatr 1999;11:108-114.
2. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end stage renal disease with recombinant human erythropoietin. N Engl J Med 1987;310: 73-78.
3. Carlini RG, Obialo CI, Rothstein M: Intravenous erythropoietin (rHuEpo) administration increases plasma endothelin and blood pressure in hemodialysis patients. Am J Hypertens 1993;6:103-107.
4. Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M: Recombinant human erythropoietin (rHuEpo) increases endothelin-1 release by endothelial cells. Kidney Int 1993;43: 1010-1014.
5. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
6. Brunet P, Lorec AM, Leonetti F, Roubicek C, Jaber K, Roux F, Berland Y: Plasma endothelin in hemodialysis patients treated with recombinant human erythropoietin. Nephrol Dial Transplant 1994;9:650-654.
7. Sasai-Takedatsu M, Kojima T, Hirata Y, Kobayashi Y: Recombinant human erythropoietin accelerates endothelin-1 production in a premature infant. Acta Paediatr Jpn 1994;36: 460-461.
8. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M: Erythropoietin has mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990;87:5978-5982.
9. Carlini RG, Reyes AA, Rothstein M: Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995;47:740-745.
10. Coceani F, Armstrong C, Kelsey L: Endothelin is a potent vasoconstrictor of the lamb ductus arteriosus. Can J Physiol 1989;67:902-904.
11. Haegerstrand A, Hemsen A, Gillis LC, Larsson O, Lundberg JM: Endothelin: presence in human umbilical vessels, high levels in fetal blood and potent constrictor effect. Acta Physiol Scand 1989;137:541-542.
12. Yamanouchi I, Igarashi I: Arterial catheters, endothelin, and ROP. Pediatrics 1992;88:874-875.
13. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH: Elevated immunoreactive endothelin-1 levels in infants with persistent pulmonary hypertension of the newborn. J Pediatr 1993;123:109.
14. Weir FJ, Ohlsson A, Fong K, Amankwah K, Coceani F: Does endothelin-1 reduce superior mesenteric artery blood flow velocity in preterm neonates? Arch Dis Child Fetal Neonatal Ed 1999;80:123-127.
15. Hegyi T, Anwar M, Carbone MT, Ostfeld B, Hiatt M, Koons A, Pinto-Martin J, Paneth N: Blood pressure ranges in premature infants. II. The first week of life. Pediatrics 1996;97:336-342.
16. Ohls RK, Veerman MW, Christensen RD: Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in parenteral nutrition solution. J Pediatr 1996;128:518-523.
17. Meyer MP, Meyer HM, Commerford A, Hann FM, Sive AA, Moller G, Jacobs P, Malan AF: Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study. Pediatrics 1994;93:918-923.
18. Ohls RK, Osborne KA, Christensen RD: Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized, placebo controlled trial. J Pediatr 1995;126:421-426.
19. Takahashi K, Totsune K, Mouri T: Endothelin in chronic renal failure. Nephron 1994;66:373-379.